The market is expected to expand at a 6.4% CAGR over the period between 2016 and 2024, and rise to a valuation of US$3.1 bn by 2024.
Albany, NY -- (SBWIRE) -- 09/20/2016 -- This report on the cardiovascular monitoring and diagnostic devices market analyzes the current and future scenario of the global market. Stroke, heart failure, and other prominent cardiovascular diseases are increasing the usage of cardiovascular monitoring and diagnostic devices. Rising geriatric population and unhealthy diet are the major drivers of the global cardiovascular monitoring and diagnostic devices market.
Complete Report with TOC @ http://www.mrrse.com/crdiovascular-monitoring-diagnostic-devices-market
The cardiovascular monitoring and diagnostic devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about different segments of the market. It also provides information and data analysis of the global market with respect to the segments based on products and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global cardiovascular monitoring and diagnostic devices market.
Based on product, the market has been segmented into ECG systems, event monitors, Holter monitors, implantable loop recorders, and ECG management systems. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.
Geographically, the global cardiovascular monitoring and diagnostic devices market has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, and Rest of Europe), Asia Pacific (Japan, China, India, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World. The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The research study also covers the competitive scenario in these regions.
Request a Free Sample Copy of the Report @ http://www.mrrse.com/sample/330
The report also profiles major players in the global cardiovascular monitoring and diagnostic devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Boston Scientific Corporation, Fukuda Denshi Co. Ltd., GE Healthcare, Hill-Rom Holdings, Inc., Johnson & Johnson, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Philips Healthcare, Siemens Healthcare, Spacelabs Healthcare (OSI Systems, Inc.), and St. Jude Medical, Inc., among others.
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.